Insider · CIK 0001754371

Cook Jennifer E.

Reports to the SEC for 3 companies · DUBLIN 4

sec.gov

Transactions

Companies

Filings

CIK

0001754371

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−14 sh	$244.06	−$3,416.9	12,428
2026-08-31	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,692 sh	$241.39	−$408K	10,736
2026-08-05	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+1,605 sh	—	—	12,442
2026-07-09	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19K sh	$8.45	+$161K	27,383
2026-07-09	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+112K sh	$29.00	+$3.26M	139,805
2026-07-09	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$16.75	+$288K	156,972
2026-07-09	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−36.2K sh	$84.00	−$3.04M	120,805
2026-07-09	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−112K sh	$90.00	−$10.1M	8,383
2026-07-09	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−19K sh	—	—	0
2026-07-09	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−112K sh	—	—	0
2026-07-09	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	0
2026-06-24	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$8.45	+$169K	28,383
2026-06-24	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$16.75	+$288K	45,550
2026-06-24	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−37.2K sh	$70.00	−$2.6M	8,383
2026-06-24	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	19,000
2026-06-24	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	17,167
2026-06-23	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−2,196 sh	$68.57	−$151K	8,383
2026-06-22	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+3,990 sh	—	—	10,579
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,277 sh	—	—	5,277
2026-06-15	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+65.9K sh	$8.45	+$557K	79,662
2026-06-15	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$16.75	+$288K	96,829
2026-06-15	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−88.7K sh	$66.62	−$5.91M	8,092
2026-06-15	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−1,503 sh	$67.14	−$101K	6,589
2026-06-15	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−65.9K sh	—	—	39,000
2026-06-15	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	34,334
2026-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,408 sh	—	—	32,483
2026-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,226
2025-08-08	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,805 sh	$111.25	−$201K	10,837
2025-08-07	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,507 sh	—	—	12,642
2025-06-20	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+6,589 sh	—	—	13,741
2025-06-20	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,425 sh	—	—	8,425
2025-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,037 sh	—	—	26,075
2025-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,111
2024-08-06	JAZZJazz Pharmaceuticals plcF Tax Payment	Director	FTax Payment	−1,484 sh	$111.35	−$165K	9,135
2024-08-02	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,731 sh	—	—	10,619
2024-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,014
2024-06-06	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−1,458 sh	$21.73	−$31.7K	20,038
2024-05-31	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,967 sh	—	—	21,496
2024-05-31	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,901
2023-12-04	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−417 sh	$119.27	−$49.7K	6,888
2023-08-14	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−1,241 sh	$138.16	−$171K	7,305
2023-08-11	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+3,075 sh	—	—	8,546
2023-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.5K sh	—	—	51,501
2023-06-01	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+4,216 sh	—	—	15,529
2023-06-01	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.6K sh	—	—	12,649
2022-12-02	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−420 sh	$154.68	−$65K	5,471
2022-08-08	JAZZJazz Pharmaceuticals plcS Sale	Director	SSale	−1,089 sh	$152.32	−$166K	5,891
2022-08-05	JAZZJazz Pharmaceuticals plcA Award	Director	AAward	+2,561 sh	—	—	6,980
2022-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,921
2022-06-02	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,986 sh	—	—	11,313

Recent filings

Accepted (ET)
Sep 24
Cook Jennifer E.0001754371-26-000007
SEC(opens sec.gov)
Aug 74
Cook Jennifer E.0001754371-26-000004
SEC(opens sec.gov)
Jul 134
Cook Jennifer E.0001470831-26-000708
SEC(opens sec.gov)
Jun 244
Cook Jennifer E.0001470831-26-000636
SEC(opens sec.gov)
Jun 174
Cook Jennifer E.0001470831-26-000550
SEC(opens sec.gov)

Companies

Address

5TH FL, WATERLOO EXCHANGE WATERLOO RD

DUBLIN 4